LPL Financial
OVID icon

LPL Financial’s Ovid Therapeutics OVID Stock Holding History

LPL Financial’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$162K Buy
65,131
+15,031
+30% +$39.3K ﹤0.01% 5900
2026
Q2 		$135K Sell
50,100
-19,448
-28% -$50.2K ﹤0.01% 5860
2026
Q1 		$154K Buy
69,548
+39,548
+132% +$70.7K ﹤0.01% 5580
2025
Q4 		$48.9K Buy
30,000
+18,000
+150% +$27.7K ﹤0.01% 5702
2025
Q3 		$15.6K Buy
+12,000
New +$10.4K ﹤0.01% 5753

Other funds holding OVID

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Total Clarity Wealth Management
Total Clarity Wealth Management St. Charles, Illinois $518M AUM 17.26% 1-Year Est. Return

LPL Financial's OVID Position: Q3 2026 in Review

LPL Financial increased its Ovid Therapeutics (OVID) stake by 30% in Q3 2026, buying an estimated $39.3K and bringing the position to 65,131 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #5900.

LPL Financial first reported a position in OVID in Q3 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

  • LPL Financial held 65,131 shares of Ovid Therapeutics worth $162K as of Q3 2026.
  • LPL Financial bought 15,031 Ovid Therapeutics shares in Q3 2026, an estimated $39.3K.
  • Ovid Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5900 holding.
  • LPL Financial first reported a position in Ovid Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.